Demandez au CCPP


Demandez au CPPP est un système de questions-réponses qui vous permet de poser des questions de manière anonyme au CCPP. Ils publient ensuite régulièrement leurs réponses dans ces archives. Si votre question nécessite une attention plus immédiate, nous vous encourageons à contacter directement le CCPP. Veuillez vous assurer de poser votre question en anglais. Pour consulter le Code d’acceptation de la publicité du CCPP, veuillez cliquer ici.

Questions mises à jour jusqu’au: 4 octobre 2021

Soumettre votre question de façon anonyme


Were there any complaints in 2021?

Yes. Please see the 2021 complaint report.


Can a skincare clinic advertise promotion, such as Botox/ laser promotion, providing off-label treatment, claiming 100% effective as well as encouraging immune IV drip to the customers?

No. Please see the following Health Canada issued Q&A.


Hello, if at a booth for an in person conference, we are only sharing materials that have already been (individually) PAAB approved. Is a new PAAB submission required for the booth ?

Yes. Please see Myth 1 and 7 for further clarification.


As references are not typical in patient information materials, do patient website submissions to PAAB require referencing?

For review purposes, PAAB requires the copy deck to have references in order to validate the copy. The published website does not require references.


Is it acceptable to put a Sales Representative image as part of a VAE signature? So at the bottom of the PAAB approved email.

The PAAB logo is presented on pieces that are approved by PAAB. Any alteration to that piece, renders the display of the PAAB logo invalid. It should be submitted for re-review with a placeholder for the reps image. Please reach out to PAAB with the specifics of the eFile in order to determine next steps.


This question relates to PAAB code 3.2.3 (information on ongoing trials)

Q1: Can you please confirm the elements that can be included in an APS - Study design, objectives, endpoints?

Q2: We are assuming that when the code states 'ongoing' it means prior to an NOC which includes a trial that is no longer recruiting but collecting data.

Q1: Yes, study design, objectives and endpoints, can be presented in a non-promotional manner per code section 3.2.3. Remember that the study must still be in the data gathering stage, with no interim analyses having been performed (including safety analysis), and it must be disclaimed accordingly.

Q2: Please see Q&A 537 and Q&A 223.

Retour en haut